Inter-Toe Cracks: A Cosmetic Response versus Excipient. Efficacy and Tolerance Evaluation

Adeline Jeudy^1,2,3, Thomas Lihoreau^1,2,3, Ferial Fanian^1,2,3, Rafat Messikh^1,2,3, Christine Lafforgue^1,2,3, Philippe Humbert^1,2,3*

¹Research and Studies Center on the Integument (CERT), Department of Dermatology, Besancon University Hospital, Besancon, France.
²Clinical Investigation Center (CIC Inserm 1431), Besancon University Hospital, Besancon, France.
³Inserm UMR1098, FED4234 IBCT, Besancon University Hospital, Besancon, France.

DOI: 10.4236/jcdsa.2015.54035                

Abstract

A randomized, monocentric, double-blind, intra-individual excipient-controlled comparative study was performed to evaluate the efficacy and tolerance of an active peptide (laminin 5 fragment [LN-5]) formulated in cosmetic balm, versus excipient in inter-toe cracks. Two products were tested on 10 healthy volunteers. Each of them suffered from this particular superficial wound characterized by a peeling off a skin tab between at least two inter-toe spaces. The duration of this study belonged of 28 days with an intermediate visit to D14. Initial and outcome evaluation was performed using a 4-grade-scale depending on the severity of the inter-toe cracks. Tolerance and healing were assessed using macrophotographs. At D14 and D 28, the difference of cure between the 2 treatments was in favor of the peptide active product. The clinical score showed a best efficiency of the active compared with the excipient; indeed a significant difference between D28 and D0 was observed for the active ingredient. Active product repairs more quickly inter-toes cracks than the excipient and we noted the complete disappearance of the “severe” and “moderate” stages from the 14^th day. This study showed clearly a fast (in 14 days) and beneficial effect of the application of LN-5 compared with the excipient, on the cutaneous repair of inter-toes cracks. Since LN-5 fragment is capable of producing immediate biological activity and reinforcing the dermal-epidermal junction, it can accelerate tissue repair.

Keywords

Formulation, Laminin 5, Inter-Toe Cracks, Healing Process, Double-Blind Clinical Study

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Cribier, B. and Grosshans, E. (2002) Histologie de la peau normale et lésions histopathologiques élémentaires. Encycl Med Chir Dermatol, 98-085-A-10.
[2]	Rousselle, P., Douglas, R.K., Ruggiero, F., et al. (1997) Laminin 5 Binds the NC-1 Domain of Type VII Collagen. Journal of Cell Biology, 138, 719-728. http://dx.doi.org/10.1083/jcb.138.3.719
[3]	Decline, F. and Rousselle, P. (2001) Keratinocyte Migration Requires Alpha2 Beta1 Integrin Mediated Interaction with the Laminin 5 Gamma 2 Chain. Journal of Cell Science, 114, 811-823.
[4]	Hull, M.T. and Warfel, K.A. (1983) Age-Related Changes in the Cutaneous Basal Lamina: Scanning Electron Microscopic Studies. Journal of Investigative Dermatology, 81, 378-380. http://dx.doi.org/10.1111/1523-1747.ep12519989
[5]	Min, S.K., Lee, S.C., Hong, S.D., et al. (2010). The Effect of a Laminin-5-Derived Peptide Coated onto Chitin Microfibers on Re-Epithelialization in Early-Stage Wound Healing. Biomaterials, 31, 4725-4730. http://dx.doi.org/10.1016/j.biomaterials.2010.02.045
[6]	Nguyen, B.P., Ryan, M.C., Gil, S.G. and Carter, W.G. (2000) Deposition of Laminin 5 in Epidermal Wounds Regulates Integrin Signaling and Adhesion. Current Opinion in Cell Biology, 12, 554-562. http://dx.doi.org/10.1016/S0955-0674(00)00131-9